IM Cannabis Corp. (CSE: IMCC)
Market Cap | 6.47M |
Revenue (ttm) | 49.88M |
Net Income (ttm) | -14.09M |
Shares Out | 2.23M |
EPS (ttm) | -6.34 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 2,000 |
Open | 2.900 |
Previous Close | 2.850 |
Day's Range | 2.900 - 2.900 |
52-Week Range | 1.440 - 10.680 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 13, 2024 |
About IM Cannabis
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers medical cannabis dried flowers; and full-spectrum, strain-specific cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv, Israel. [Read more]
Financial Performance
In 2023, IM Cannabis's revenue was 48.80 million, a decrease of -10.18% compared to the previous year's 54.34 million. Losses were -9.50 million, -94.97% less than in 2022.
Financial StatementsNews
IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors
TORONTO and GLIL YAM, Israel , Sept. 11, 2024 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (NASDAQ: IMCC) (CSE: IMCC), a leading medical cannabis company with operations in Israel and G...
IM Cannabis reports Q2 results
IM Cannabis reports second-quarter financial results with GAAP EPS of -C$0.23 and revenue of C$14.8M, up 12.1% year-over-year.
IM Cannabis reports Q2 results
IM Cannabis reports second-quarter financial results with GAAP EPS of -C$0.23 and revenue of C$14.8M, up 12.1% year-over-year.
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:NASDAQ:IMCC) Q2 2024 Earnings Conference Call August 14, 2024 9:00 AM ETCompany ParticipantsAnna Taranko - Director of Investor...
IM Cannabis Corp. (IMCC) Q2 2024 Earnings Call Transcript
IM Cannabis Corp. (NASDAQ:NASDAQ:IMCC) Q2 2024 Earnings Conference Call August 14, 2024 9:00 AM ETCompany ParticipantsAnna Taranko - Director of Investor...
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results on Wednesday for the second quarter ended June 30, 2024 , revealing a 12% yea...
IM Cannabis Reports Second Quarter Financial Results
IMC Germany delivers +200% in sales in first three months after German legalization, while overall revenue grows 12% vs Q2 2023 TORONTO and GLIL YAM, Israel, Aug. 14, 2024 /PRNewswire/ -- IM Cannabis ...
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
IM Cannabis Medical cannabis company IM Cannabis Corp . (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 202...
IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET
TORONTO and GLIL YAM, Israel , Aug. 6, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in ...
IM Cannabis regains compliance with Nasdaq
IM Cannabis (IMCC) regains compliance with Nasdaq minimum bid price requirement per formal notice.
IM Cannabis regains compliance with Nasdaq
IM Cannabis (IMCC) regains compliance with Nasdaq minimum bid price requirement per formal notice.
IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement
TORONTO and GLIL YAM, Israel , July 29, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in...
IM Cannabis Shares Surge 586% After 6:1 Consolidation: What Investors Need To Know
IM Cannabis Corp. IMCC, a leading medical marijuana company announced that its common shares are trading on a 6:1 post-consolidated basis.
IM Cannabis Shares Commence Trading on 6:1 Consolidated Basis
TORONTO and GLIL YAM, Israel , July 12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IM Cannabis"), a leading medical cannabis company with operations in Israel...
CSE Bulletin: Consolidation - IM Cannabis Corp. (IMCC)
Toronto, Ontario--(Newsfile Corp. - Le 9 juillet/July 2024) - IM Cannabis Corp. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated comm...
IM Cannabis Announces Intention to Complete Consolidation
TORONTO and GLIL YAM, Israel, July 5, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IM Cannabis", or "IMC"), a leading medical cannabis company with operations in ...
IMCC Addresses Accelerated Growth in Germany Through new Supply Agreement with EU-GMP Certified Glasshouse Botanics and Announces a Change to its Board of Directors
IMC Germany's accelerated growth potential leans strongly on its supply strategy through its ability to partner with cannabis growers for EU-GMP certification, bolstering the company's supply chain wi...
IM Cannabis Closes Convertible Debenture Offering to Support Accelerated Growth in Germany
Through continuous, active cost management, IMC reduced its annual G&A costs by 49% in 2023 and is now looking to significantly reduce its financial costs. TORONTO and GLIL YAM, Israel , May 29, 2024 ...
IM Cannabis Corp. (IMCC) Q1 2024 Earnings Call Transcript
IM Cannabis Corp. [IMCC] Q1 2024 Earnings Conference Call May 8, 2024 9:00 AM ET Company Participants Oren Shuster - CEP Uri Birenberg - CFO Anna Taranko - IR Conference Call Participants Scott fortun...
IM Cannabis Reports First Quarter Financial Results
IMC prepares for accelerated growth after legalization in Germany and recovers from the impact of the Israel-Hamas war. TORONTO and GLIL YAM, Israel , May 8, 2024 /PRNewswire/ -- IM Cannabis Corp. (th...
IM Cannabis to Report First Quarter 2024 Financial Results on Wednesday, May 8th at 9:00am ET
TORONTO and GLIL YAM, Israel , May 1, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in I...
IMC to transfer its Oranim Pharmacy shares back to the seller
TORONTO and GLIL YAM, Israel , April 16, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Ge...
2024's Breakout Cannabis Stocks: Who Made the Triple-Digit Leap
In the ever-evolving landscape of the US cannabis industry, marijuana stocks have been lighting up the market, with some experiencing triple-digit gains in the last month. Investors are keenly watchin...
IM Cannabis and Flora Growth Partner to Bring Vessel Cannabis Accessories to the Israeli Market
TORONTO and GLIL YAM, Israel , April 9, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in...
Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market
TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with ...